Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
The Clorox Company
CLX
NYSE·Consumer Defensive·Household & Personal Products·Mkt cap $11.7B
$97.26
▲ +0.87%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$84.70 - $132.03
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 22.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Strong brand recognition
- Diverse product portfolio
- Established distribution channels
- Consumer trust and loyalty
Bear Case
1 risk
- Low volatility (beta 0.5).
Growth
Moderate growth ahead
E-commerce expansion
Value
Fairly valued vs Household Products peers
Momentum
Stable
-4.7% over 3m
Quality
Strong
Strong fundamentals
Dividend
High yield
5.14% yield
Smart-money signal
Who's buying CLX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Jul 30, 2026
APR 30, 2026
Reported EPS of $1.64 vs $1.55 consensus (+5.8% surprise). Revenue of $1.7B vs $1.7B expected (+0.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+5.8%
Next: Jul 30, 2026
Revenue trend · last 8Q
—
—
-15%
-8%
+4%
-19%
-1%
+0%
Q4 24
Q1 24
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
Q3 26
$1.9B
$1.8B
$1.7B
$1.7B
$2.0B
$1.4B
$1.7B
$1.7B
Margins · last 8Q
Gross
43.2%
Operating
17.3%
Profit
11.2%
Wall Street consensus
11 analysts · 9% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
9%
Hold
55%
Sell
36%
Median Price Target
$96.50
▼ -0.8% vs $97.26
Latest: Wells Fargo · May 18, 2026
9 analysts covering